1887
Volume 2007, Issue 1
  • ISSN: 0253-8253
  • E-ISSN: 2227-0426

Abstract

Records of patients attending the Andrology Clinic, Hamad Medical Corporation, Qatar; over a period often years were analyzed to determine the demographic features, contributory risk factors, and best methods of treatment for erectile dysfunction (ED). Of1,245patients with ages ranging from 19-78 years (mean 49 years) 45% were Qataris. Most complained of weak erections, a few reported ejaculatory dysfunction. Diabetes mellitus was the most frequent risk factor (53%) followed by hypertension (28%), smoking (27%) and coronary artery disease (14%). Oral Sildenafil given to 310 patients gave overall satisfaction to 75 (49%) of the 152 patients in whom satisfaction could be assessed; intracorporal injection given to 413 patients resulted in overall satisfaction to 107 (68%) of 157 in whom satisfaction could be assessed; penile prosthesis implantation in 64 patients remained an effective therapeutic modality with 31 (84%) of the 37 patients in whom satisfaction could be assessed being satisfied with the results.

Conclusion: Erectile dysfunction is as common in Qatar as it is in the rest of the world. The higher incidence of diabetes mellitus in the ED. population in the region forms the major risk factor and might reflect the need for the implementation of preventive strategies.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2007.1.10
2007-06-01
2019-09-16
Loading full text...

Full text loading...

References

  1. 1. Abdulbari   B. . Annual Statistical Report (2002) for health services provided in Qatar. . Report from Ministry of Public Health & Hamad Medical Corporation . 2003; ; : 117 .
    [Google Scholar]
  2. 2. Hermann   M., , Berger   P. . Hormonal changes in aging men: A therapeutic indication?.   Exp Gerontol . 2001; ;36: : 1075 .
    [Google Scholar]
  3. 3. Schulman   CC. . The aging male: a challenge for urologists. . Curr Opin Urol . 2000; ;10: : 337 .
    [Google Scholar]
  4. 4. Seyam   RM., , Albakry   A., , Ghobish   A., , Arif   H., , Dandash   K., , Rashwan   H. . Prevalence of erectile dysfunction and its correlates in Egypt: A community-based study. . Int J Impot Res . 2003; ;15: : 237 .
    [Google Scholar]
  5. 5. Safarinejad   MR. . Prevalence and risk factors for erectile dysfunction in a population-based study in Iran. . Int J Impot Res . 2003; ;15: : 246 .
    [Google Scholar]
  6. 6. Dunn   KM., , Croft   PR., , Hackett   GI. . Sexual problems: A study of the prevalence and need for health care in the general population. . Fam Pract . 1998; ;15: : 519 .
    [Google Scholar]
  7. 7. Rosen   RC. . Prevalence and risk factors of sexual dysfunction in men and women. . Curr Psychiatry Rep . 2000; ;2: : 189 .
    [Google Scholar]
  8. 8. Verma   KK., , Khaitan   BK., , Singh   OP. . The frequency of sexual dysfunctions in patients attending a sex therapy clinic in north India. . Arch Sex Behav . 1998; ;27: : 309 .
    [Google Scholar]
  9. 9. Virag   R., , Beck-Ardilly   L. . Nosology, epidemiology, clinical quantification of erectile dysfunctions. . Rev Med Interne . 1997; ;18: Suppl 1 : 10 .
    [Google Scholar]
  10. 10. Dorey   G. . Is smoking a cause of erectile dysfunction? A literature review. . Br J Nurs . 2001; ;10: : 455 .
    [Google Scholar]
  11. 11. Al Helali   NS., , Abolfotouh   MA., , Ghanem   HM. . Pattern of erectile dysfunction in Jeddah city. . Saudi Med J . 2001; ;22: : 34 .
    [Google Scholar]
  12. 12. Bortolotti   A., , Fedele   D., , Chatenoud   L., , Colli   E., , Coscelli   C., , Landoni   M., , Lavezzari   M., , Santeusanio   F., , Parazzini   F. . Cigarette smoking: a risk factor for erectile dysfunction in diabetics. . Eur Urol . 2001; ;40: : 392 .
    [Google Scholar]
  13. 13. Braun   M., , Sommer   F., , Lehmacher   W., , Raible   A., , Bondarenko   B., , Engelmann   U. . [Erectile dysfunction]. . Dtsch Med Wochenschr . 2004; ;129: : 131 .
    [Google Scholar]
  14. 14. Sanchez de la Vega   J., , Amaya Gutierrez   J., , Alonso Flores   JJ., , Garcia Perez   M. . Erectile dysfunction in those under 40. Etiological and contributing factors. . Arch Esp Urol . 2003; ;56: : 161 .
    [Google Scholar]
  15. 15. Roth   A., , Kalter-Leibovici   O., , Kerbis   Y., , Tenenbaum-Koren   E., , Chen   J., , Sobol   T., , Raz   I. . Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: a community survey among 1,412 Israeli men. . Clin Cardiol . 2003; ;26: : 25 .
    [Google Scholar]
  16. 16. Margolis   SACT., , Dunn   EV., , Reed   RL. . The health status of community based elderly in the United Arab Emirates. . Arch Gerontol Geriatr.   2003; ;37: : 1 .
    [Google Scholar]
  17. 17. Nehra   A. . Treatment of endocrinologic male sexual dysfunction. . Mayo Clin Proc . 2000; ;75: : S40 .
    [Google Scholar]
  18. 18. Bodie   J., , Lewis   J., , Schow   D., , Monga   M. . Laboratory evaluations of erectile dysfunction: an evidence based approach. . J Urol . 2003; ;169: : 2262 .
    [Google Scholar]
  19. 19. Earle   CM., , Stuckey   BG. . Biochemical screening in the assessment of erectile dysfunction: what tests decide future therapy?.   Urology . 2003; ;62: : 727 .
    [Google Scholar]
  20. 20. De la Torre Holguera   P., , Hernandez   J., , over   D., , Marti Malet   J., , Ochoteco Garcia   J I. . Assessment of erectile dysfunction with Doppler-duplex ultrasonography. . Arch Esp Urol . 2001; ;54: : 617 .
    [Google Scholar]
  21. 21. Abdel-Hamid   IA., , Eraky   I., , Fouda   MA., , Mansour   OE. . Role of penile vascular insufficiency in erectile dysfunction in renal transplant recipients. . Int J Impot Res . 2002; ;14: : 32 .
    [Google Scholar]
  22. 22. Gresser   U., , Gleiter   CH. . Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil—review of the literature. . Eur J Med Res . 2002; ;7: : 435 .
    [Google Scholar]
  23. 23. Tsujimura   A., , Yamanaka   M., , Takahashi   T., , Miura   H., , Nishimura   K., , Koga   M., , Iwasa   A., , Takeyama   M., , Matsumiya   K., , Takahara   S., , Okuyama   A. . The clinical studies of sildenafil for the ageing male. . Int J Androl . 2002; ;25: : 28 .
    [Google Scholar]
  24. 24. Amar   E., , Kobelinsky   M., , Khoury   R., , Sarkis   P., , Bouyer   I., , Dauphin   A., , Delmas   V., , Boccon-Gibod   L. . Treatment of sexual impotency by intra-cavernous injections of prostaglandin El. Report of 180 patients. . Prog Urol . 1993; ;3: : 971 .
    [Google Scholar]
  25. 25. Tan   HL. . Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members. . Pharmacoeconomics . 2000; ;17: : 77 .
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/qmj.2007.1.10
Loading
  • Article Type: Research Article
Keyword(s): demographic pattern , Erectile dysfunction and prevalence of risk factors
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error